Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Dibitetto

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urologia|April 15, 2022
Laser technology in urologic oncologyMauro Ragonese, Francesco Dibitetto, PierFrancesco Bassi, et al.
Medical Sciences (Basel, Switzerland)|June 1, 2022
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and PerspectivesFrancesco Pinto, Francesco Dibitetto, Mauro Ragonese, et al.
Urologia Internationalis|January 9, 2024
Staghorn Caliceal Hem-o-lok Stone: A Long-Term Complication of Robotic Partial Nephrectomy - A Case Report and Literature ReviewFrancesco Dibitetto, Pierluigi Russo, Filippo Marino, et al.
Journal of Robotic Surgery|February 13, 2024
Partial nephrectomy series using Versius robotic surgical system: technique and outcomes of an initial experienceIacopo Meneghetti, Maria Chiara Sighinolfi, Francesco Dibitetto, et al.
Urologia|April 29, 2026
Miniaturized laser enucleation of the prostate (MiLEP) is feasible and safe: 12-month follow-up, real-life, prospective multicenter studyLuca Cindolo, Marco Domenico Salvaggio, Cesare Mario Scoffone, et al.
Minerva Urology and Nephrology|August 2, 2024
Extraperitoneal robot-assisted radical prostatectomy by the da Vinci and Versius System: first comparative analysisFrancesco Dibitetto, Roberto Castellucci, Pierluigi Russo, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?Pierluigi Russo, Filippo Marino, Francesco Rossi, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 27, 2026
Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-UpIacopo Meneghetti, Francesco Dibitetto, Alberto Mariotti, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urologia|April 15, 2022
Laser technology in urologic oncologyMauro Ragonese, Francesco Dibitetto, PierFrancesco Bassi, et al.
Medical Sciences (Basel, Switzerland)|June 1, 2022
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and PerspectivesFrancesco Pinto, Francesco Dibitetto, Mauro Ragonese, et al.
Urologia Internationalis|January 9, 2024
Staghorn Caliceal Hem-o-lok Stone: A Long-Term Complication of Robotic Partial Nephrectomy - A Case Report and Literature ReviewFrancesco Dibitetto, Pierluigi Russo, Filippo Marino, et al.
Journal of Robotic Surgery|February 13, 2024
Partial nephrectomy series using Versius robotic surgical system: technique and outcomes of an initial experienceIacopo Meneghetti, Maria Chiara Sighinolfi, Francesco Dibitetto, et al.
Urologia|April 29, 2026
Miniaturized laser enucleation of the prostate (MiLEP) is feasible and safe: 12-month follow-up, real-life, prospective multicenter studyLuca Cindolo, Marco Domenico Salvaggio, Cesare Mario Scoffone, et al.
Minerva Urology and Nephrology|August 2, 2024
Extraperitoneal robot-assisted radical prostatectomy by the da Vinci and Versius System: first comparative analysisFrancesco Dibitetto, Roberto Castellucci, Pierluigi Russo, et al.
Medicina (Kaunas, Lithuania)|December 23, 2023
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?Pierluigi Russo, Filippo Marino, Francesco Rossi, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|February 27, 2026
Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-UpIacopo Meneghetti, Francesco Dibitetto, Alberto Mariotti, et al.
Pageof 1